StockData

Cognex vs Keysight Technologies

CGNX and KEYS side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CGNX and KEYS compare

Keysight Technologies is the larger company, worth 6.1 times as much as Cognex ($51.8B against $8.5B).

On earnings, Cognex is cheaper: it trades at 35.5× trailing earnings, against 41.7× for Keysight Technologies.

Keysight Technologies grew revenue faster over the last twelve months (25.5% versus 15.8% for Cognex).

Cognex keeps more of each dollar of sales as profit, with a net margin of 21.5% compared with 19.1% at Keysight Technologies.

Cognex pays a dividend yielding 0.67%; Keysight Technologies does not pay one.

Cognex scores higher on the StockData Score (19 against 14 for Keysight Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCGNXKEYS
Size and price
Market cap$8.5B$51.8B
Share price$50.77$304.23
Change, 1 year32.2%66.7%
Change, 5 years−36.5%56.3%
Beta (5Y)1.301.42
Employees2,26717K
StockData Score
Total score19 (better)14
Valuation score3 (better)1
Growth score3 (better)2
Performance score45 (better)
Health score66
Dividend score3 (better)0
Valuation
P/E35.5× (better)41.7×
P/S7.6× (better)7.9×
P/B5.0× (better)7.9×
EV/EBITDA27.9× (better)38.8×
P/FCF29.9× (better)35.3×
FCF yield3.3% (better)2.8%
Fair value$57.31$234.92
Margin of safety11.4% (better)−29.5%
Growth
Revenue growth (TTM)15.8%25.5% (better)
Revenue growth, 5Y average4.2%5.0% (better)
Net income growth (TTM)120%132% (better)
EPS growth (TTM)123%132% (better)
EPS growth, 5Y average−7.4%8.2% (better)
Profitability
Gross margin69.7% (better)64.7%
Operating margin25.0% (better)20.3%
Net margin21.5% (better)19.1%
FCF margin25.4% (better)22.3%
Return on equity15.1%20.6% (better)
Return on invested capital20.6%21.3% (better)
Financial health
Debt / equity0.000.38 (better)
Net debt / EBITDA–−0.07
Interest coverage–12.3×
Current ratio5.04 (better)2.02
Altman Z-score10.91 (better)7.95
Piotroski F-score8 (better)6
Dividends and buybacks
Dividend yield0.67%–
Payout ratio23.5%–
Years of dividend growth4–
Dividend growth, 5Y average−31.9%–
Buyback yield1.5% (better)1.2%
Shareholder yield2.2% (better)1.2%
Ownership
Held by institutions104%90.6%
Held by insiders0.38%0.72%
Insider net buying, 12 months−$34.8M−$27.7M (better)
Superinvestors holding–2
Short interest, % of float3.9%1.3%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.